Conditions: Glioblastoma
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 34
Healthy volunteers: no

Brief summary:
The purpose of this study is to find out whether the new drug PX-866 will slow the growth of your glioblastoma multiforme.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: PX-866
Intervention descriptions: intervention 1: 1 cycle = 8 weeks on study PX-866 - 8mg PO Daily

Protocol document: